Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Soligenix receives E.U. orphan designation for RiVax

March 23, 2018

Institute of Radiation Medicine presents novel compounds protecting against radiation

March 19, 2018

Japanese researchers disclose PDE7 inhibitors

March 15, 2018

University of Bristol presents new alpha4beta2 nicotinic receptor partial agonists

March 8, 2018

Anti-heroin vaccine demonstrates efficacy in rodents

March 7, 2018

Sublocade becomes available as first and only monthly injectable buprenorphine in the U.S.

March 2, 2018

NOP agonist AT-312 can reduce alcohol reward

Feb. 26, 2018

Pain Therapeutics resubmits Remoxy ER NDA

Feb. 14, 2018

Opiant Pharmaceuticals announces plans for intranasal nalmefene

Feb. 13, 2018

V1B receptor antagonism may enhance alcohol dependency treatment

Feb. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...